Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Standard Biotools (LAB) Operating Margin (2016 - 2025)

Standard Biotools (LAB) has disclosed Operating Margin for 16 consecutive years, with 103.57% as the latest value for Q4 2025.

  • Quarterly Operating Margin fell 43622.0% to 103.57% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 109.77% through Dec 2025, down 7955.0% year-over-year, with the annual reading at 129.2% for FY2025, 10834.0% down from the prior year.
  • Operating Margin for Q4 2025 was 103.57% at Standard Biotools, up from 168.46% in the prior quarter.
  • The five-year high for Operating Margin was 332.65% in Q4 2024, with the low at 205.37% in Q2 2022.
  • Average Operating Margin over 5 years is 67.46%, with a median of 83.46% recorded in 2023.
  • The sharpest move saw Operating Margin skyrocketed 42309bps in 2021, then plummeted -43622bps in 2025.
  • Over 5 years, Operating Margin stood at 68.8% in 2021, then fell by -14bps to 78.13% in 2022, then surged by 280bps to 140.6% in 2023, then surged by 137bps to 332.65% in 2024, then crashed by -131bps to 103.57% in 2025.
  • According to Business Quant data, Operating Margin over the past three periods came in at 103.57%, 168.46%, and 118.08% for Q4 2025, Q3 2025, and Q2 2025 respectively.